AcelRx Pharmaceuticals Inc. (ACRX)

3.15
0.25 8.62
NASDAQ : Health Technology
Prev Close 2.90
Open 3.00
Day Low/High 2.95 / 3.15
52 Wk Low/High 1.55 / 5.75
Volume 820.72K
Avg Volume 478.80K
Exchange NASDAQ
Shares Outstanding 51.32M
Market Cap 148.83M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We trimmed one position for a hefty gain last week, as the portfolio delivered very favorable performance on both an absolute and relative basis.

Stocks Under $10 Weekly Summary

We added 2 new positions during a week of solid performance for the portfolio.

Stocks Under $10 Weekly Summary

We added to three positions during a mixed week for the market.

Stocks Under $10 Weekly Summary

During a down week for the market, we exited one name and added to another.

Finally Significant News on a Health Care Position

Here’s our plan for AcelRx Pharmaceuticals leading up to earnings.

AcelRx Receives Positive CHMP Opinion For DZUVEO™ For Management Of Acute Moderate To Severe Pain In Medically Monitored Settings

DZUVEO is AcelRx's second developed sublingual sufentanil-based product to receive positive CHMP opinion, with Zalviso® already approved

Stocks Under $10 Weekly Summary

We initiated one position and closed out another last week.

Stocks Under $10 Weekly Summary

We added to two positions during a week when nearly all of our holdings moved higher.

Stocks Under $10 Weekly Summary

We exited one name and added to another during a wild week for stocks.

Stocks Under $10 Weekly Summary

The portfolio had several market outperformers last week and we took some profits in one high-flying position.

Stocks Under $10 Weekly Summary

We added 2 Bullpen names during a challenging week for the market.

Stocks Under $10 Weekly Summary

During a ‘noisy’ week for the portfolio, we added a small speculative position in a payment-processing name.

Trimming One Position, Adding to Another

We will sell shares of AcelRx Pharmaceuticals and buy more Black Box.

Stocks Under $10 Weekly Summary

The strength exhibited by the Russell 2000 paved the way for portfolio last week.

Everything Is Coming Up Roses

New price target on Kush Bottles plus a rocking employment report.

Stocks Under $10 Weekly Summary

We threw in the towel last week on 2 positions and initiated a small stake in an ancillary cannabis play.

Stocks Under $10 Weekly Summary

During a shortened trading week we closed out of one position and added to another after earnings reports.

Stocks Under $10 Weekly Summary

We shed two positions last week as the market roared back.

Stocks Under $10 Weekly Summary

We added to several positions on weakness during a challenging last week for the stock market.

Stocks Under $10 Weekly Summary

We exited one position and added to another as volatility returned to the stock market last week.

TheStreet Quant Rating: D- (Sell)